Tandem Diabetes Care (TNDM) Accounts Payables (2013 - 2026)
Tandem Diabetes Care's (TNDM) quarterly Accounts Payables came in at $59.9 million in Q1 2026, little changed YoY from $59.8 million in Q1 2025, and up 27.18% on a QoQ basis from $47.1 million in Q4 2025.
Tandem Diabetes Care (TNDM) Accounts Payables (2013 - 2026) Analysis & Trends
Tandem Diabetes Care (TNDM) has 14 years of Accounts Payables data on file, last reported at $59.9 million in Q1 2026.
- Quarterly Accounts Payables changed 0.1% year-over-year to $59.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $59.9 million (changed 0.1% YoY) and the FY2025 annual result came in at $47.1 million, up 5.22% from the prior year.
- Accounts Payables climbed to $59.9 million in Q1 2026, from $47.1 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $61.5 million in Q3 2022 to a low of $44.7 million in Q4 2024.
- A 5-year average of $51.8 million and a median of $49.6 million in 2023 frame the typical range for Accounts Payables.
- Annual changes were most pronounced in 2022 — Accounts Payables jumped 128.12% — and 2023, when it decreased 25.01%.
- Tracing TNDM's Accounts Payables over 5 years: stood at $55.7 million in 2022, then decreased by 11.02% to $49.6 million in 2023, then decreased by 9.79% to $44.7 million in 2024, then gained by 5.22% to $47.1 million in 2025, then increased by 27.18% to $59.9 million in 2026.
- The last three Accounts Payables figures came in at $59.9 million (Q1 2026), $47.1 million (Q4 2025), and $47.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 4.79 Bn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 1.66 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 2.64 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 1.23 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 210.50 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 3.23 Bn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 2.42 Bn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 344.10 Mn |
| 10 | Tandem Diabetes Care | 1.57 Bn | 1.11 Bn | 144.78 Mn | 64.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 64.13 Mn |
| Mar 31, 2026 | 59.86 Mn |
| Dec 31, 2025 | 47.07 Mn |
| Sep 30, 2025 | 47.48 Mn |
| Jun 30, 2025 | 55.84 Mn |
| Mar 31, 2025 | 59.80 Mn |
| Dec 31, 2024 | 44.73 Mn |
| Sep 30, 2024 | 48.75 Mn |
| Jun 30, 2024 | 47.78 Mn |
| Mar 31, 2024 | 48.14 Mn |
| Dec 31, 2023 | 49.59 Mn |
| Sep 30, 2023 | 46.14 Mn |
| Jun 30, 2023 | 57.08 Mn |
| Mar 31, 2023 | 55.23 Mn |
| Dec 31, 2022 | 55.73 Mn |
| Sep 30, 2022 | 61.53 Mn |
| Jun 30, 2022 | 50.66 Mn |
| Mar 31, 2022 | 45.34 Mn |
| Dec 31, 2021 | 28.03 Mn |
| Sep 30, 2021 | 26.97 Mn |